Inhibitory factors of serum opsonic activity in serum from patients with chronic renal failure

被引：4
|
作者：
Kikuchi, T
Nigawara, K
Sugawara, K
Nakaji, S
Abe, T
Satoh, H
机构：
[1] Department of Hygiene, Hirosaki University, School of Medicine, Aomori
[2] OYOKYO Kidney Research Institute, Hirosaki Hospital, Aomori
[3] Department of Hygiene, Hirosaki University, School of Medicine, Hirosaki, Aomori 036
来源：
RENAL FAILURE | 1997年 / 19卷 / 01期
关键词：
D O I：
10.3109/08860229709026268
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
We investigated the mechanism of impaired serum opsonic activity in patients suffering from chronic renal failure (CRF). Prehemodialysis pooled serum from CRF patients was fractionated using Sephadex G-50 gel chromatography, and the effects of the obtained fractions on serum opsonic activity were examined using luminal-dependent chemiluminescence responses. Number 25-30 fractions in the prehemodialysis serum contained factors that may inhibit serum opsonic activity. The presumed molecular weight of these fractions is between 300 and 2800 daltons. These findings indicate that the inhibitory factors of serum opsonic activity may belong to middle molecules.
引用
收藏
页码：137 / 144
页数：8
相关论文
共 50 条
  • [1] OXIDATIVE-METABOLISM OF POLYMORPHONUCLEAR LEUKOCYTES AND SERUM OPSONIC ACTIVITY IN CHRONIC RENAL-FAILURE
    LUCCHI, L
    CAPPELLI, G
    ACERBI, MA
    SPATTINI, A
    LUSVARGHI, E
    NEPHRON, 1989, 51 (01) : 44 - 50
  • [2] SERUM INHIBITORY FACTORS AND E-ROSETTES IN CHRONIC-RENAL-FAILURE
    RAPTOPOULOUGIGI, M
    KYRIAKOPOULOS, G
    GOULIS, G
    THYMUS, 1980, 1 (4-5) : 281 - 285
  • [3] The serum paraoxonase activity in patients with chronic renal failure and hyperlipidemia
    Paragh, G
    Seres, I
    Balogh, Z
    Varga, Z
    Kárpáti, I
    Mátyus, J
    Ujhelyi, L
    Kakuk, G
    NEPHRON, 1998, 80 (02) : 166 - 170
  • [4] SERUM ANTIHEPARIN ACTIVITY IN CHRONIC RENAL FAILURE
    VAVRIK, M
    EXPERIENTIA, 1964, 20 (10): : 583 - &
  • [5] The serum paraoxonase activity changes in patients with chronic renal failure and in patients with hyperlipidemia
    Paragh, G
    Seres, I
    Balogh, Z
    Varga, Z
    Karpati, I
    Matyus, J
    Ujhelyi, L
    Kakuk, G
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 216 - 216
  • [6] SERUM GASTRIN AND SERUM CALCITONIN IN PATIENTS WITH CHRONIC RENAL-FAILURE
    CHRISTENSEN, CK
    NIELSEN, HE
    KAMSTRUP, O
    OLSEN, KJ
    BRANDSBORG, M
    BRANDSBORG, O
    ACTA ENDOCRINOLOGICA, 1979, 91 (03): : 564 - 570
  • [7] Decrease of serum paraoxonase activity in chronic renal failure
    Dantoine, TF
    Debord, J
    Charmes, JP
    Merle, L
    Marquet, P
    Lachatre, G
    Leroux-Robert, C
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1998, 9 (11): : 2082 - 2088
  • [8] SERUM LIPASE ACTIVITY IN CHRONIC RENAL-FAILURE
    SOMMER, H
    KASPER, H
    FOSEL, T
    ACTA HEPATO-GASTROENTEROLOGICA, 1975, 22 (04): : 248 - 252
  • [9] BASAL AND POSTCIBAL SERUM GASTRIC INHIBITORY POLYPEPTIDE CONCENTRATIONS IN PATIENTS WITH CHRONIC RENAL-FAILURE
    ODORISIO, TM
    SIRINEK, KR
    PACE, WG
    MAZZAFERRI, EL
    CATALAND, S
    GASTROENTEROLOGY, 1976, 70 (05) : 924 - 924
  • [10] Serum magnesium levels in patients with chronic renal failure
    Dosoo, DK
    Nunoo, A
    Amanquah, SD
    CLINICAL CHEMISTRY, 2004, 50 (06) : A57 - A57
12345